The Advisory Board Company was a big mover last session, as the company saw its shares rise over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $50.95 to $54.20 in the past one-month time frame.

The upside was driven by rumors that UnitedHealth Group Inc. and Vista Equity Partners are nearing a deal to acquire and split up Advisory Board.

The company has seen a mixed track record when it comes to estimate revision of no increases and one decrease over the past few months, while the Zacks Consensus Estimate for the current quarter remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Advisory Board currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.

The Advisory Board Company Price and Consensus

A better-ranked stock in the Medical sector is Nobilis Health Corp. (HLTH Quick QuoteHLTH - Free Report) , which also carries a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.

Is ABCO going up? Or down? Predict to see what others think: Up or Down

Will You Make a Fortune on the Shift to Electric Cars?

Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.

With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.

It's not the one you think.

See This Ticker Free >>